Trade Abbott ^ABT

Pharmaceutical Stocks To Watch Now - February 3rd - Markets Daily

Abbott CEO Share Purchase Highlights $21b Exact Sciences Deal And Valuation

Sollinda Capital Management LLC Sells 15,866 Shares of Abbott Laboratories $ABT

Jones Financial Companies Lllp Buys 61,627 Shares of Abbott Laboratories $ABT

Abbott Laboratories $ABT Stake Lessened by Thrivent Financial for Lutherans

Abbott Labs CEO makes $2M bet as stock sinks

Abbott Laboratories (ABT): A Bull Case Theory - Insider Monkey

Why Abbott Labs CEO Robert Ford is betting $2M on ABT dip | ABT

Best Pharmaceutical Stocks To Watch Today - February 1st - Markets Daily

Barclays Lowers Abbott Laboratories (NYSE:ABT) Price Target to $142.00 - Markets Daily

Abbott Laboratories (NYSE:ABT) Price Target Cut to $142.00 by Analysts at Barclays - Stock Observer

Medical Stocks To Keep An Eye On - February 1st - Markets Daily

Top Pharmaceutical Stocks To Add to Your Watchlist - January 31st - Markets Daily

Principal Financial Group Inc. Sells 331,362 Shares of Abbott Laboratories $ABT

Freedom Capital Upgrades Abbott Laboratories (ABT) to Buy

Abbott Laboratories (NYSE:ABT) Given New $119.00 Price Target at Leerink Partners - Markets Daily

Daiwa Capital Markets Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price

Abbott Laboratories (NYSE:ABT) Rating Increased to Strong-Buy at Freedom Capital

Private Wealth Partners LLC Purchases 12,025 Shares of Abbott Laboratories $ABT

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $113.00 at Daiwa Capital Markets - Stock Observer

Summit Global Investments Lowers Stock Holdings in Abbott Laboratories $ABT

Abbott Laboratories (NYSE:ABT) Raised to "Strong-Buy" at Freedom Capital - Stock Observer

Best Medical Stocks To Research - January 28th - Stock Observer

AE Wealth Management LLC Raises Stock Holdings in Abbott Laboratories $ABT

Abbott Laboratories (NYSE:ABT) Price Target Cut to $119.00 by Analysts at Leerink Partners - Daily Political

Abbott Resets Nutrition While Expanding Diagnostics And Device Growth Drivers

National Pension Service Has $477.60 Million Position in Abbott Laboratories $ABT - Daily Political

Medical Stocks To Watch Today - January 30th

Decent Organic Sales Growth Expected for Abbott Laboratories (ABT) in 2026

This beaten-down sector could offer you a ripe investment opportunity | Morningstar

Everett Harris & Co. CA Trims Stock Position in Abbott Laboratories $ABT

Townsquare Capital LLC Sells 17,856 Shares of Abbott Laboratories $ABT - Daily Political

Great Lakes Advisors LLC Has $179.83 Million Holdings in Abbott Laboratories $ABT

New York State Common Retirement Fund Decreases Stake in Abbott Laboratories $ABT

Abbott Laboratories $ABT Shares Bought by Mirae Asset Global Investments Co. Ltd. - Daily Political

How New Price Targets Are Shaping The Evolving Story For Abbott Laboratories (ABT)

Cardiovascular Surgical Devices Market Competitive Analysis Report 2025: Key Players, Company Profiles, Strategic Developments, Mergers, Product Innovations, Revenue Insights, and Future Forecasts

Abbott Laboratories (NYSE:ABT) Given New $140.00 Price Target at Argus - Markets Daily

Abbot (ABT) is a High Quality Company, Says Jim Cramer

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $140.00 at Argus - Stock Observer

Abbott Laboratories $ABT Shares Sold by Bank of New York Mellon Corp

Abbott Laboratories $ABT Holdings Cut by Truist Financial Corp - Stock Observer

Phoenix Financial Ltd. Sells 7,773 Shares of Abbott Laboratories $ABT - Daily Political

What To Expect From Stryker's (SYK) Q4 Earnings

Is Abbott (ABT) Insider Buying Offsetting Concerns Around Nutrition and Diagnostics Earnings Pressure?

Lbp Am Sa Boosts Stock Holdings in Abbott Laboratories $ABT

Abbott Laboratories (NYSE:ABT) Receives $140.79 Consensus PT from Brokerages - Daily Political

Abbott Reworks Nutrition While Targeting Cancer Diagnostics With Exact Sciences Deal

Evercore ISI Says Abbott's (ABT) Core Growth Drivers Are Still Intact

Top Pharmaceutical Stocks To Keep An Eye On - January 26th - Markets Daily

Hedge Fund and Insider Trading News: Ken Griffin, Bill Ackman, Mala Gaonkar, Millennium Management, Berkshire Hathaway, Abbott Laboratories (ABT), GameStop Corp (GME), and More

Milk Powder Market Report 2026: Industry Forecast to Reach $6.19 Billion by 2030, Driven Rising Demand for Shelf-Stable Dairy Products in Regions with Limited Cold-Chain Infrastructure

Parthenon LLC Has $2.91 Million Position in Abbott Laboratories $ABT - Stock Observer

Abbott Laboratories $ABT Shares Sold by Trek Financial LLC - Stock Observer

Piper Sandler Cuts Abbott Laboratories (NYSE:ABT) Price Target to $135.00 - Daily Political

Abbott Laboratories $ABT Shares Sold by TrueMark Investments LLC - Stock Observer

Medical Stocks Worth Watching - January 24th - Markets Daily

Analysts Conflicted on These Healthcare Names: Intuitive Surgical (ISRG) and Abbott Laboratories (ABT) | Markets Insider

Abbott Laboratories (NYSE:ABT) Shares Gap Down - What's Next? - Markets Daily

Abbott Laboratories $ABT Shares Purchased by Mitsubishi UFJ Trust & Banking Corp

Abbott Laboratories (ABT) Margin Compression Challenges Steady Compounder Narrative After FY 2025 Results

UniSuper Management Pty Ltd Buys 44,239 Shares of Abbott Laboratories $ABT - Stock Observer

Mn Services Vermogensbeheer B.V. Acquires 9,900 Shares of Abbott Laboratories $ABT - Daily Political

Abbott Laboratories (NYSE:ABT) Receives Consensus Rating of "Moderate Buy" from Brokerages

Abbott Laboratories $ABT Shares Sold by Gibbs Wealth Management - Daily Political

Abbott Laboratories (NYSE:ABT) Issues Q1 2026 Earnings Guidance - Daily Political

Assessing Abbott Laboratories (ABT) Valuation After Q4 2025 Earnings Miss And Softer 2026 Guidance

Citigroup Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00

Best Medical Stocks To Keep An Eye On - January 23rd - Markets Daily

The Goldman Sachs Group Cuts Abbott Laboratories (NYSE:ABT) Price Target to $140.00 - Markets Daily

Abbott Laboratories (NYSE:ABT) Price Target Cut to $135.00 by Analysts at Royal Bank Of Canada - Markets Daily

Contrasting Abbott Laboratories (NYSE:ABT) & DiaSorin (OTCMKTS:DSRLF)

Sanford C. Bernstein Lowers Abbott Laboratories (NYSE:ABT) Price Target to $125.00

Abbott Faces Near-Term Headwinds in Nutrition and Slower Long-Term Libre Growth | Morningstar

Abbott Laboratories (NYSE:ABT) Price Target Cut to $132.00 by Analysts at Oppenheimer

Abbott Laboratories (NYSE:ABT) Given New $130.00 Price Target at Raymond James Financial

Abbott Laboratories (NYSE:ABT) Price Target Lowered to $135.00 at Royal Bank Of Canada

Evercore ISI Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price

Abbott Laboratories (NYSE:ABT) Price Target Cut to $135.00 by Analysts at Piper Sandler - Markets Daily

Abbott Laboratories (NYSE:ABT) Given New $140.00 Price Target at BTIG Research - Markets Daily

Piper Sandler Issues Pessimistic Forecast for Abbott Laboratories (NYSE:ABT) Stock Price

Abbott Laboratories (NYSE:ABT) Price Target Cut to $140.00 by Analysts at BTIG Research

Abbott Laboratories (NYSE:ABT) Q4 2025 Earnings Call Transcript

NVE Corporation (NASDAQ:NVEC) Q3 2026 Earnings Call Transcript

The Goldman Sachs Group Has Lowered Expectations for Abbott Laboratories (NYSE:ABT) Stock Price - Stock Observer